Statement on Dr. Bertagnolli’s Nomination as NIH Director
We applaud President Biden for announcing his intent to nominate Monica Bertagnolli, MD, as Director of the National Institutes of Health. Dr. Bertagnolli is a leader who brings vision, hands-on-experience, and heart to a role that demands all three attributes.
Dr. Bertagnolli joined the federal government in October 2022 when she was appointed Director of the National Cancer Institute, the largest institute within NIH. Prior to leading NCI, Dr. Bertagnolli served as a surgeon at Brigham and Women’s Hospital (a Research!America member) as well as professor of surgery at Harvard Medical School.
Strong, visionary leadership is a hallmark of NIH, and we are confident Dr. Bertagnolli will continue that storied legacy. The potential created by past research investment opens the door to unprecedented medical and public health progress. We believe Dr. Bertagnolli is the right leader at the right time to ensure NIH fulfills its crucial role in the public-private sector R&D ecosystem, paving the way for desperately needed solutions for deadly and debilitating health threats. Our nation will be well served by her leadership, and we urge Congress to act quickly to confirm her nomination as soon as possible.
- Mary Woolley, Research!America President and CEO
- Sudip Parikh, PhD, Research!America Board Chair
Contact Tim Haynes, Senior Director of Communications, at 571-482-2737 or thaynes@researchamerica.org with press inquiries.